Marker Therapeutics Announces First Lymphoma Patient

Marker Therapeutics initiated APOLLO trial for the treatment of lymphoma patients who have relapsed after anti-CD19 CAR T therapy in the first quarter of...

Related Keywords

United States ,Houston ,Texas ,Casey Mcdonald ,Daniel Kontoh Boateng ,Juanf Vera ,Nasdaq ,Baylor College Of Medicine ,Marker Therapeutics Inc ,Baylor College ,Marker Therapeutics ,Monic Stuart ,Chief Medical Officer ,Chief Executive Officer ,Private Securities Litigation Reform Act ,